Hamartomatous polyposis syndrome associated malignancies: Risk, pathogenesis and endoscopic surveillance

J Dig Dis. 2021 Aug;22(8):444-451. doi: 10.1111/1751-2980.13029. Epub 2021 Jul 8.

Abstract

Hamartomatous polyposis syndromes (HPS) are a heterogeneous spectrum of diseases that are characterized by diffuse hamartomatous polyps lining the gastrointestinal (GI) tract together with extra-GI manifestations. Classical HPS includes juvenile polyposis syndrome, Peutz-Jeghers syndrome, PTEN hamartoma tumor syndrome and hereditary mixed polyposis syndrome. Patients with HPS have a higher risk of GI and extra-GI malignancies than the general population, although the underlying mechanisms remain unclear and are obviously different from the carcinogenesis of classical adenocarcinoma and colitis-associated malignancy. In this review we aimed to clarify the risks, possible mechanism and endoscopic surveillance of HPS-associated GI malignancies.

Keywords: adenoma-carcinoma sequence; endoscopic surveillance; hamartomatous polyposis syndrome.

Publication types

  • Review

MeSH terms

  • Hamartoma Syndrome, Multiple* / complications
  • Hamartoma Syndrome, Multiple* / genetics
  • Humans
  • Intestinal Polyposis* / complications
  • Intestinal Polyposis* / genetics
  • Intestinal Polyps
  • Neoplastic Syndromes, Hereditary / complications
  • Neoplastic Syndromes, Hereditary / genetics
  • Peutz-Jeghers Syndrome / complications
  • Peutz-Jeghers Syndrome / genetics